Wells Fargo initiated coverage on Hamilton Lane with a new price target
$HLNE
Investment Managers
Finance
Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/21/2025 | $186.00 | Perform → Outperform | Oppenheimer |
| 1/6/2025 | $139.00 | Neutral → Sell | Goldman |
| 9/12/2024 | $156.00 | Equal Weight | Wells Fargo |
| 4/11/2024 | $115.00 | Overweight → Neutral | JP Morgan |
| 1/11/2024 | Outperform → Perform | Oppenheimer | |
| 5/26/2023 | $87.00 | Perform → Outperform | Oppenheimer |
| 3/15/2023 | $85.00 | Neutral → Overweight | JP Morgan |
| 8/9/2022 | $72.00 → $75.00 | Buy → Neutral | UBS |
Research findings note some areas of concern in private markets in the short-term, with positive tailwinds across long-term fundamentals Report also highlights strong runway for growth within evergreenCONSHOHOCKEN, Pa., March 12, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment management firm, published its 2025 Market Overview today. This year's report offers a nuanced picture of the global private markets landscape, backed by historical data around outperformance, downside risk and diversification benefits, as well as a burgeoning evergreen landscape, demonstrating its compelling case for a growing number of investors.
Fund leverages firm's 24+ years of experience in the secondary market and extensive scale to capitalize on what the firm believes to be attractive long-term growth trends CONSHOHOCKEN, Pa., March 3, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Private Secondary Fund ("HLPSF" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Company Act of 1940 ("40 Act"), available to U.S. accredited investor clients, including sufficiently qualified high-net-worth investors and their wealth advisors. HLPSF offers private wealth and institutional investo
-- Acquisition Propels Cosette Into One Of The Leading Companies In Women's Health and Dermatology in the U.S. -- -- Highly Complementary Business Strengthens Cosette's Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach -- -- Utilizing Mayne Pharma's Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD
SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)
8-K - Hamilton Lane INC (0001433642) (Filer)
424B5 - Hamilton Lane INC (0001433642) (Filer)
Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo
Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is
The firm broadens its co-investment capabilities with the additions of five senior team membersGlobal appointments highlight continued growth within the asset class and historic success of the firm's Direct Equity platform, which stands at $15.3 billion in AUM* CONSHOHOCKEN, Pa., Nov. 12, 2024 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced the expansion of its Direct Equity Investment Team, with the appointment of five new senior team members based in North America and Europe to support the continued growth of the asset class.
Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00
Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00
Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
4 - Hamilton Lane INC (0001433642) (Issuer)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
SC 13G/A - Hamilton Lane INC (0001433642) (Subject)
CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year
CONSHOHOCKEN, Pa., Jan. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the third fiscal quarter before the market opens on Tuesday, February 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on February 4 to discuss the results for the third fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website clicking here (https://shareholders.hamiltonlane.com/) at least 15 minutes prior to the sta
Together with Republic, this initiative seeks to revolutionize access to private markets funds, opening a $13 trillion* global market to retail investors CONSHOHOCKEN, Pa. and NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), one of the largest private markets investment firms globally, together with Republic, a leading global investment platform for private market assets, today announced a new partnership that aims to bring institutional-quality private market investments to individual retail investors in the U.S. Through the partnership, the firms intend to launch digital blockchain-based solutions for retail investors, featuring low investment minimums and the pot